Cited2tm3.1Bha
Targeted Allele Detail
|
Symbol: |
Cited2tm3.1Bha |
Name: |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2; q targeted mutation 3.1, Shoumo Bhattacharya |
MGI ID: |
MGI:5472019 |
Synonyms: |
Cited2T166N |
Gene: |
Cited2 Location: Chr10:17598966-17601422 bp, + strand Genetic Position: Chr10, 7.18 cM, cytoband A2
|
Alliance: |
Cited2tm3.1Bha page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:192202
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
129
|
|
Allele Type: |
|
Targeted (Humanized sequence) |
Mutations: |
|
Insertion, Nucleotide substitutions
|
|
|
Mutation details: A C to A transversion results in the amino acid substitution of arginine for threonine at position 166 (T166N). Flp-mediated recombination removed the FRT-flanked neo cassette inserted downstream of the modification.
(J:192202)
|
|
Generation of the Cited2tm3.1Bha allele |
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Cited2 Mutation: |
23 strains or lines available
|
|
Original: |
J:192202 Chen CM, et al., Functional significance of SRJ domain mutations in CITED2. PLoS One. 2012;7(10):e46256 |
All: |
1 reference(s) |
|